Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MLYCD | O95822 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.30 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11983878 | 0.81 | ALDH1A1 (0.35) | ALDH1A1TSHRATM | |
| SCHEMBL13192023 | 0.78 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL23219622 | 0.78 | TSHR (0.36) | ALDH1A1TSHRNFKB1EPHX2GAA | |
| SCHEMBL2477172 | 0.76 | FOLH1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL14883007 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TSHRATM | |
| SCHEMBL4168233 | 0.73 | TSHR (0.44) | ALDH1A1TSHR | |
| SCHEMBL16203275 | 0.73 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL13644386 | 0.73 | TDP1 (0.41) | ALDH1A1TSHREPHX2GAA | |
| SCHEMBL31634583 | 0.72 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL11957433 | 0.71 | ABCG2 (0.34) | MLYCDEPHX2PLA2G10PLA2G5GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975042-B2 | Method for purifying an amino acid-n-carboxy anhydride | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10975042-B2 | Method for purifying an amino acid-n-carboxy anhydride | NAAA, NPPA, NCAPH | ALDH1A1 1912/4885TSHR 2201/4885MLYCD 3508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.